Skip to Main Content
Table 2

The mRNA expression of selected EGF family members in human bladder tumors

Ta median (range)T1 median (range)T2–T4 median (range)
AR (10−21 mol/μg RNA) 0.21 (0.0–23.5) 0.45 (0.0–4.85) 0.65 (0.0–8.17) 
βCL (10−21 mol/μg RNA) 8.0 (0.2–127) 14.2 (0.0–1390) 16.3 (0.0–1630) 
Ta median (range)T1 median (range)T2–T4 median (range)
AR (10−21 mol/μg RNA) 0.21 (0.0–23.5) 0.45 (0.0–4.85) 0.65 (0.0–8.17) 
βCL (10−21 mol/μg RNA) 8.0 (0.2–127) 14.2 (0.0–1390) 16.3 (0.0–1630) 
EGFLowLowLow
EPI (10−21 mol/μg RNA) 0.9 (0.0–20.9) 1.6 (0–18.4) 6.5a (0.0–144.7) 
HB-EGF (10−21 mol/μg RNA) 8.5 (0.0–229.1) 34.4 (1.6–80.4) 50.0a (0.0–2001) 
TGF-α (10−21 mol/μg RNA) 0.4 (0.0–6.8) 1.0 (0.0–24.7) 4.9b (0.0–120.6) 
HER1 (10−19 mol/μg RNA) 0.17 (0.0–24.4) 1.01 (0.0–85.1) 0.77 (0.0–76.4) 
HER2 (10−19 mol/μg RNA) 325 (0.0–4570) 1530 (0.0–1610) 293 (0.0–4140) 
EGFLowLowLow
EPI (10−21 mol/μg RNA) 0.9 (0.0–20.9) 1.6 (0–18.4) 6.5a (0.0–144.7) 
HB-EGF (10−21 mol/μg RNA) 8.5 (0.0–229.1) 34.4 (1.6–80.4) 50.0a (0.0–2001) 
TGF-α (10−21 mol/μg RNA) 0.4 (0.0–6.8) 1.0 (0.0–24.7) 4.9b (0.0–120.6) 
HER1 (10−19 mol/μg RNA) 0.17 (0.0–24.4) 1.01 (0.0–85.1) 0.77 (0.0–76.4) 
HER2 (10−19 mol/μg RNA) 325 (0.0–4570) 1530 (0.0–1610) 293 (0.0–4140) 
a

P < 0.001.

b

P < 0.05.

Close Modal

or Create an Account

Close Modal
Close Modal